HomeInsightsPE

Shilpa Medicare Ltd PE Ratio

Shilpa Medicare Ltd PE Ratio

stocks purchased

₹ 4.6 Cr

Volume Transacted

(Dec 11, 2024)

stocks purchased

52.5 K

Stocks Traded

(Dec 11, 2024)

Last Updated on: Dec 12, 2024

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

PE

149.9

Last updated on: Dec 12, 2024

Key Highlights

  • The P/E Ratio of Shilpa Medicare Ltd is 149.9 as of 12 Dec 10:05 AM .
  • The P/E Ratio of Shilpa Medicare Ltd changed from 24.7 on March 2019 to 125.7 on March 2024 . This represents a CAGR of 31.15% over 6 years.
  • The Latest Trading Price of Shilpa Medicare Ltd is ₹ 879.7 as of 11 Dec 15:30 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.5. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Shilpa Medicare Ltd

No data available

Company Fundamentals for Shilpa Medicare Ltd

No data available

Image

Shilpa Medicare Ltd

NSE: SHILPAMED

Share Price

₹ 879.7

42.45 (5.07%)

stock direction

Last updated on: Dec 11, 2024

Market Price of Shilpa Medicare Ltd

1M

1Y

3Y

5Y

Monitoring Shilpa Medicare Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
11 Dec 2024879.7
10 Dec 2024837.25
09 Dec 2024836.3
06 Dec 2024856.4
05 Dec 2024853.9
04 Dec 2024867.9
03 Dec 2024891.45
02 Dec 2024900.15
29 Nov 2024898.75
28 Nov 2024895.05

SWOT Analysis Of Shilpa Medicare Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Shilpa Medicare Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Shilpa Medicare Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Shilpa Medicare Ltd1498,602
Sun Pharmaceuticals Industries Ltd384,35,407
Divis Laboratories Ltd851,57,489
Cipla Ltd251,17,443
Torrent Pharmaceuticals Ltd651,14,197
Mankind Pharma Ltd491,05,098

Key Valuation Metric of Shilpa Medicare Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Revenue of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical EBITDA of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Net Profit of Shilpa Medicare Ltd

No data available

* All values are in crore

Historical Dividend Payout of Shilpa Medicare Ltd

No data available

* All values are in %

About Shilpa Medicare Ltd

  • Shilpa Medicare Limited (Formerly known as Shilpa Antibiotics Private Limited) was incorporated as a Private Limited Company on November 20, 1987.
  • The Company changed the status to Public Limited and the name of the Company was changed to Shilpa Antibiotics Limited in November, 1993 and later on, was changed to 'Shilpa Medicare Limited' on February 17, 2003. The Company has been promoted by Vishnukant C. Bhutada and his Associates and is engaged in manufacturing of API, Formulation and Development service.
  • The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka.
  • It then started commercial production in November, 1989. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology.

Shilpa Medicare Ltd News Hub

News

Shilpa Medicare to conduct AGM

Shilpa Medicare announced that the 37th Annual General Meeting (AGM) of the company will b...

Read more

2024-08-16 00:00:00

News

Shilpa Medicare consolidated net profit rises 1091.53% in the June 2024 quarter

Net profit of Shilpa Medicare rose 1091.53% to Rs 14.06 crore in the quarter ended June 20...

Read more

2024-08-08 00:00:00

News

Shilpa Medicare to announce Quarterly Result

Shilpa Medicare will hold a meeting of the Board of Directors of the Company on 8 August 2...

Read more

2024-08-02 00:00:00

News

Shilpa Medicare update on its CDMO customer - Unicycive Therapeutics

Unicycive Therapeutics, Inc. (NASDAQ: UNCY) announced the submission of NDA to U.S. FDA fo...

Read more

2024-09-04 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Shilpa Medicare Ltd

What is the current PE Ratio of Shilpa Medicare Ltd?

The Current PE Ratio of Shilpa Medicare Ltd is 149.86 as on 12 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 12 Dec 2024.

What was the PE Ratio of Shilpa Medicare Ltd last year?

The PE Ratio of Shilpa Medicare Ltd was 0.0 last year, now the PE ratio is 149.86, showing a year-on-year growth of -%.

What does the PE Ratio of Shilpa Medicare Ltd indicate about its stock?

The PE Ratio of Shilpa Medicare Ltd is 149.86. This ratio indicates that investors are willing to pay 149.86 times the earnings per share for each share of Shilpa Medicare Ltd.

What is the PE Ratio Growth of Shilpa Medicare Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Shilpa Medicare Ltd grew by -% whereas, the EPS ratio grew by 25.3.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions